Joe Hsueh is the General Manager and COO of AnBogen Therapeutics. He leads finance operation and business development with his expertise in venture capital and pharmaceutical industries in Taiwan, China and U.S. As the Chief Operating Officer of ACT Genomics. His role was to lead finance operation, sales/ marketing and business development team to foresee business opportunities for future growth. Mr. Hsueh brings over 15 years of experience in operations, finance and business development at a reputable biopharmaceutical company, TaiGen Biotechnology in Taiwan. Prior to joining ACT Genomics, Mr. Hsueh has led TaiGen Biotechnology in Taiwan to complete 2 series, co-conducted 1 series of financing and successfully closed in total of 114 Million US$ within 7 years, inked an out-licensing deal, and involved in various tasks and business networking in Biopharmaceuticals/ Pharmaceutical industry. Before TaiGen Biotechnology, he had worked for Chengxin VC and led fund-raising for 6 companies in the States and Taiwan. Mr. Hsueh holds an MBA degree from Fairleigh Dickinson University in USA, and B.A. in Microbiology from Soochow University in Taiwan.